ProVue Lung
Proteomics-based blood LDT designed to complement LDCT lung-cancer screening in high-risk adults.
- Developer
- PrognomiQ
- Intended use
- Screening
- Cancer scope
- Not reported
- Specimen
- Peripheral whole blood
- Molecular modality
- Protein
- Current version
- ProVue Lung current LDT
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.